Ulland Investment Advisors LLC Lowers Stock Position in UnitedHealth Group Incorporated $UNH

Ulland Investment Advisors LLC reduced its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 20.5% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 7,441 shares of the healthcare conglomerate’s stock after selling 1,915 shares during the period. UnitedHealth Group accounts for 1.8% of Ulland Investment Advisors LLC’s portfolio, making the stock its 18th biggest holding. Ulland Investment Advisors LLC’s holdings in UnitedHealth Group were worth $2,321,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also recently made changes to their positions in UNH. Brighton Jones LLC raised its stake in UnitedHealth Group by 176.2% during the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock valued at $22,384,000 after purchasing an additional 28,231 shares during the period. Revolve Wealth Partners LLC raised its stake in UnitedHealth Group by 137.1% during the 4th quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock valued at $2,033,000 after purchasing an additional 2,324 shares during the period. GAMMA Investing LLC raised its stake in UnitedHealth Group by 7.4% during the 1st quarter. GAMMA Investing LLC now owns 15,838 shares of the healthcare conglomerate’s stock valued at $8,295,000 after purchasing an additional 1,089 shares during the period. Simon Quick Advisors LLC raised its stake in UnitedHealth Group by 25.1% during the 1st quarter. Simon Quick Advisors LLC now owns 6,381 shares of the healthcare conglomerate’s stock valued at $3,342,000 after purchasing an additional 1,280 shares during the period. Finally, Net Worth Advisory Group raised its stake in UnitedHealth Group by 0.6% during the 1st quarter. Net Worth Advisory Group now owns 3,642 shares of the healthcare conglomerate’s stock valued at $1,907,000 after purchasing an additional 21 shares during the period. 87.86% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several analysts recently issued reports on the company. Bank of America lifted their target price on UnitedHealth Group from $350.00 to $390.00 and gave the company a “neutral” rating in a research note on Wednesday. Baird R W downgraded UnitedHealth Group from a “hold” rating to a “strong sell” rating in a research note on Thursday, July 31st. Morgan Stanley lifted their price objective on UnitedHealth Group from $325.00 to $395.00 and gave the stock an “overweight” rating in a research note on Friday, September 12th. Robert W. Baird reaffirmed an “underperform” rating and issued a $198.00 price objective (down previously from $312.00) on shares of UnitedHealth Group in a research note on Thursday, July 31st. Finally, Wells Fargo & Company lifted their price objective on UnitedHealth Group from $267.00 to $400.00 and gave the stock an “overweight” rating in a research note on Tuesday. Sixteen investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and four have assigned a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $383.09.

UnitedHealth Group Price Performance

Shares of UNH stock opened at $367.69 on Friday. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $630.73. The stock has a market capitalization of $333.01 billion, a price-to-earnings ratio of 15.93, a P/E/G ratio of 2.39 and a beta of 0.47. The stock has a fifty day simple moving average of $315.87 and a two-hundred day simple moving average of $351.51. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The firm had revenue of $111.62 billion during the quarter, compared to analysts’ expectations of $111.75 billion. During the same quarter in the prior year, the company posted $6.80 earnings per share. UnitedHealth Group’s quarterly revenue was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were issued a $2.21 dividend. This represents a $8.84 annualized dividend and a dividend yield of 2.4%. The ex-dividend date was Monday, September 15th. UnitedHealth Group’s dividend payout ratio is currently 38.30%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.